Stagnation and herd mentality in the biomedical sciences

Cancer Biology and Therapy

Volumn 3, Issue 9, 2004, Pages 903-910

  Brody, Jonathan R ^a   Kern, Scott E ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Cancer Research Bldg   (United States)

Author keywords

Grants; Herd mentality; Mavericks; Meetings; Peer review; Philosophy; Publication; Research; Stagnation; Training

Indexed keywords

DNA FRAGMENT; RAS PROTEIN; RNA;

BIOMEDICINE; ELECTROPHORESIS; HERD; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR RECOGNITION; PHILOSOPHY; PUBLICATION; REVIEW; ROUS SARCOMA ONCOVIRUS; SEQUENCE HOMOLOGY; SOCIOLOGY; VALIDATION PROCESS; ARTICLE; FINANCIAL MANAGEMENT; FORECASTING; GROUP PROCESS; HUMAN; MOTIVATION; PUBLISHING; SOCIAL STATUS;

BIOMEDICAL RESEARCH; FORECASTING; GOALS; GROUP PROCESSES; HUMANS; PUBLISHING; RESEARCH SUPPORT; SOCIAL CONDITIONS;

EID: 18744390336     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.9.1082     Document Type: Review

References (54)

1. Insall R. Cynicism and credulity: My word. Curr Biol 1999; 9:R231.
2. Percy W. The Moviegoer. New York: Alfred A Knopf; 1980.
3. Kuhn TS. The structure of scientific revolutions. Chicago: University of Chicago Press, 1962.
4. Hand PH, Thor A, Wunderlich D, Muraro R, Caruso A, Schlom J. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci USA 1984; 81:5227-31.
5. Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J, et al. Expression of ras oncogene p21 in prostate cancer. N Engl J Med 1986; 314:133-7.
6. Robinson A, Williams AR, Piris J, Spandidos DA, Wyllie AH. Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas. Br J Cancer 1986; 54:877-83.
7. Samowitz WS, Paull G, Hamilton SR. Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expression. Hum Pathol 1988; 19:127-32.
8. Samowitz WS, Paull G, Hamilton SR. Monoclonal antibody RAP-5 and ras p21 expression. Human Pathol 1988; 19:1119-1120.
9. Ward JM, Perantoni AO, Santos E. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Oncogene 1989; 4:203-13.
10. National Library of Medicine. Pub Med. Search term: Rap-5, selected for content 2004.
11. Campanario JM. Fraud: Retracted articles are still being cited. Nature 2000; 408:288.
12. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: A laboratory manual. Cold spring harbor. NY: Cold Spring Harbor Laboratory; 1982.
13. Brody JR, Kern SE. Sodium boric acid: A Tris-free, cooler conductive medium for DNA electrophoresis. Biotechniques 2004; 36:214-6.
14. Brody JR, Kern SE. History and principles of conductive media for standard DNA electrophoresis. Anal Biochem 2004; In press.
15. Brody JR, Calhoun ES, Gallmeier E, Kern SE. Ultrafast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive media. Bio Techniques 2004; In press.
16. Temin HM. Homologybetween RNA from Rous sarcoma virus and DNA from Rous sarcoma virus-infected cells. Proc Natl Acad Sci USA 1964; 52:323-9.
17. Temin HM. The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro. Virology 1960; 10:182-97.
18. Temin HM. The effects of actinomycin D on growth of Rous sarcoma virus in vitro. Virology 1963; 20:577-82.
19. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970; 226:1211-3.
20. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970; 226:1209-11.
21. Baldwin N. Edison: Inventing the century. Chicago: University of Chicago Press, 2001.
22. Perutz M. I wish I'd made you angry earlier. New York: Cold Spring Harbor Laboratory Press, 1998.
23. Kern SE. Fellowship goals for Ph.Ds and MDs: A primer on the molecular biology post-doctoral experience. Cancer Biol Ther 2002; 1:74-5.
24. Wood EJ, Vella F. IUBMB updates Ph.D. standards. Bioessays 2000; 22:771-3.
25. Alberts BM, Ayala FJ, Botstein D, Frank E, Holmes EW, Lee RD, et al. Proposed changes for NIH's center for scientific review. Panel on Scientific Boundaries for Review. Center for Scientific Review Advisory Committee, National Institutes of Health. Science 1999; 285:666-7.
26. Barnes JE. Letter. The New York Times 2004.
27. Hjerten S. Dedication to professor arne tiselius. Ann NY Acad Sci 1973; 209:5-7.
28. Sindermann C. Winning the games scientists play. New York: Perseus Publishing, 2001.
29. Bergman AB. Meeting mania. N Engl J Med 1994; 330:1622-3.
30. Qiagen. http://www1.qiagen.com/Default.aspx? 2004.
31. Feynman RP. The pleasure of finding things out. New York: Perseus Publishing; 2001.
32. Weinstein IB. The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment-twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res 1988; 48:4135-43.
33. Campanario JM. Have referees rejected some of the most-cited articles of all time? J Am Soc Inform Sci 1996; 47:302-310.
34. Levy S. Crypto: How the code rebels beat the government. New York: Penguin Putnam Inc., 2002.
35. Bernal M. Black Athena. New Brunswick: Rutgers University Press, 1989.
36. Rennie D. Innovation and peer review. In: Godlee F, Jefferson T, eds. Peer review in health sciences. 2nd ed. London: BMJ Books, 2003.
37. Campanario JM. Not in our nature. Nature 1993; 361:488.
38. Kern SE, Kinzler KW, Baker SJ, Nigro JM, Rotter V, Levine AJ, et al. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 1991; 6:131-6.
39. Schutte M, da Costa LT, Hahn SA, Moskaluk C, Hoque ATMS, Rozenblum E, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 1995; 92:5950-4.
40. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51:6304-11.
41. Overbeke J, Wager E. The state of evidence: What we know and what we don't know about journal peer review. In: Godlee F, Jefferson T, eds. Peer review in health sciences. 2nd ed. London: BMJ Books, 2003.
42. McCook A. Open-access journals rank well. The Scientist 2004.
43. Unattributed. Scientists play down cancer-cure frenzy. CNN 1998.
44. Hamaguchi M, Meth JL, von Klitzing C, Wei W, Esposito D, Rodgers L, et al. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc Natl Acad Sci USA 2002; 99:13647-52.
45. Muhlbauer KR, Grone HJ, Ernst T, Grone E, Tschada R, Hergenhahn M, et al. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Br J Cancer 2003; 89:687-90.
46. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001; 294:2563-6.
47. Curtis L, Blouin JL, Radhakrishna U, Gehrig C, Lasseter VK, Wolyniec P, et al. No evidence for linkage between schizophrenia and markers at chromosome 15q13-14. Am J Med Genet 1999; 88:109-12.
48. King N, Bassett AS, Honer WG, Masellis M, Kennedy JL. Absence of linkage for schizophrenia on the short arm of chromosome 5 in multiplex Canadian families. Am J Med Genet 1997; 74:472-4.
49. Director NCI. Plan and budget proposal for fiscal year 2002. National Institutes of Health 2001.
50. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, et al. TGFBR1*6A and cancer: A meta-analysis of 12 case-control studies. J Clin Oncol 2004; 22:756-8.
51. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. Coffee and cancer of the pancreas. N Engl J Med 1981; 304:630-3.
52. Newman L. Scorpion venom: A cure for cancer? CNN 2003.
53. Steiner M. Interview with sherman Alexie. WYPR radio 2003.
54. DiFranco A. Lyrics to Fuel, Little Plastic Castle. Buffalo: Righteous Babe Records 1998.